{"id":4452,"date":"2016-09-26T09:13:41","date_gmt":"2016-09-26T13:13:41","guid":{"rendered":"https:\/\/medicarereport.org\/?p=4452"},"modified":"2016-09-26T09:13:41","modified_gmt":"2016-09-26T13:13:41","slug":"beware-the-hype-top-scientists-cautious-about-fighting-cancer-with-immunotherapy","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=4452","title":{"rendered":"Beware the hype: Top scientists cautious about fighting cancer with immunotherapy"},"content":{"rendered":"<p>(By Sharon Begley for ST<em>A<\/em>T)<\/p>\n<p><span class=\"big-cap\">N<\/span>EW YORK \u2014 There\u2019s been a lot of excitement about <a href=\"https:\/\/www.statnews.com\/2016\/01\/12\/personalized-cancer-vaccines\/\" target=\"_blank\">immunotherapy<\/a><sup class=\"footnote\">1<\/sup> as a tool to treat cancer. But as leading experts gathered here on Sunday, several\u00a0struck an unexpected note of caution. <a href=\"https:\/\/www.statnews.com\/2016\/09\/25\/cancer-immunotherapy-caution\/\" target=\"_blank\">Continue reading article here&#8230;&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"stat-logo\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<pre><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Sharon Begley for STAT) NEW YORK \u2014 There\u2019s been a lot of excitement about immunotherapy1 as a tool to<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,14],"tags":[],"class_list":["post-4452","post","type-post","status-publish","format-standard","hentry","category-emerging-health-issues","category-medical-technology"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4452","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4452"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4452\/revisions"}],"predecessor-version":[{"id":4453,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4452\/revisions\/4453"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}